Reference standard is one of those subjects where the details matter more than the headlines. This page pulls together the background, the mechanisms, and the practical points readers ask about most.
Updated 2025-09-23. Numbers and descriptions here follow the published literature rather than marketing material.
In the fitness and bodybuilding literature, cardarine is frequently discussed as an endurance agent or fat-loss compound, although such claims are not supported by robust clinical evidence. Online descriptions often mix animal data, user anecdotes, and marketing language. Researchers who study PPARδ agonists distinguish between receptor activation in controlled experiments and unsupervised use of unverified products. The latter introduces unknown purity, dose, and interactions, making reported experiences difficult to interpret scientifically.
GW501516 acts as an agonist at peroxisome proliferator-activated receptor delta, a nuclear receptor involved in transcription of genes related to lipid handling and energy use. Activation of PPARδ can shift skeletal muscle toward greater fatty acid oxidation in animal models, which is one reason it drew interest for metabolic disease and exercise research. The exact downstream effects depend on tissue, species, dose, and duration. Human data are sparse, so many proposed benefits remain hypotheses rather than established clinical outcomes.
Laboratory studies have examined GW501516 in cell cultures and rodents for conditions such as dyslipidemia, insulin resistance, and obesity. Some trials in humans were initiated, but development was discontinued after preclinical findings raised concerns about cancer in certain models. Those findings do not prove that the compound causes cancer in people, but they contributed to regulatory caution. Later reviews often describe the evidence as preliminary and insufficient for assessing long-term safety.
Preclinical research reported that GW501516 increased running endurance in mice and improved lipid profiles in some animal species. Early human trials explored effects on high-density lipoprotein cholesterol, triglycerides, and glucose handling, but the program was discontinued. Published human data are sparse and do not establish efficacy for any condition. Studies also examined PPAR delta in cancer biology, with conflicting findings across models. The relationship between receptor activation, tissue context, and disease risk remains an active area of investigation.
Anti-doping laboratories identify GW501516 and its metabolites using liquid chromatography-tandem mass spectrometry. Urine is the usual matrix, and detection can occur after the parent compound has cleared from blood. The exact detection window depends on dose, formulation, individual metabolism, and assay sensitivity. Because the compound is prohibited at all times, athletes are subject to testing in and out of competition. Analytical methods continue to improve as new metabolites and designer analogs are characterized.
GW501516 acts as a ligand for PPAR delta, a nuclear receptor that regulates transcription of genes involved in fatty acid oxidation and energy use. Activation of this receptor in skeletal muscle shifts metabolism toward fat burning in animal models. The compound does not burn fat directly; it changes gene expression over hours to days. Researchers study it to understand metabolic flexibility and exercise adaptation. Effects observed in rodents are not automatically expected in humans.
| Property | Value | Notes |
|---|---|---|
| Solubility | Soluble in dimethyl sulfoxide and some organic solvents; practically insoluble in water | Solvent choice affects laboratory handling |
| Typical storage | -20 °C, desiccated, protected from light | Common condition for research samples |
| Analytical method | Liquid chromatography–tandem mass spectrometry (LC-MS/MS) | Used for identification and quantification in biological or product samples |
| Common synonyms | GW501516, GW-501516, GSK-516, Endurobol | Names found in research and anti-doping literature |
| Regulatory status | Unapproved therapeutic; prohibited in competitive sport | Status can vary by country and context |
Laboratory detection of GW501516 commonly uses liquid chromatography coupled with tandem mass spectrometry. The method can identify the parent compound or its metabolites in urine and blood after sample cleanup. Protein precipitation, solid-phase extraction, or enzymatic hydrolysis may precede analysis, depending on the matrix. Reference standards are required for accurate quantification and confirmation. Because the compound is not approved, testing often occurs in anti-doping, forensic, or research settings rather than routine clinical care. Results are reported with limits of detection and quantification.
Stability of GW501516 depends on form, temperature, light exposure, and moisture. Solid reference material is typically stored frozen or refrigerated in a desiccator and protected from light. Solutions in organic solvents such as dimethyl sulfoxide are often kept frozen in aliquots to reduce freeze-thaw cycling. Aqueous solubility is low, so aqueous stock solutions can be difficult to prepare without cosolvents. Degradation may appear as changes in chromatographic purity or mass spectral signal. Stability studies are needed to establish shelf life for any specific preparation.
Cardarine is prohibited in competitive sport under the World Anti-Doping Agency code, where it is classified as a metabolic modulator. It is not approved as a prescription medicine in the United States, European Union, or other major markets. Regulatory action has focused on its presence in sports and in products marketed as research chemicals. Because it has no accepted medical indication, supply is often unregulated. This status creates legal and safety uncertainties for anyone who encounters the substance.
Anti-doping laboratories detect GW501516 and its metabolites using liquid chromatography-tandem mass spectrometry. Urine is the most common matrix, though blood and dried blood spots may also be used in some programs. Detection depends on factors such as dose, timing, metabolism, and the sensitivity of the assay. Published methods describe limits of detection in the low nanogram per milliliter range for related compounds. Exact detection windows are not fixed for all situations and remain an area of ongoing study.
Products sold as cardarine have been found to contain incorrect compounds, variable amounts, or no active ingredient at all. Independent testing is required to verify identity and purity. Common analytical approaches include high-performance liquid chromatography, mass spectrometry, and nuclear magnetic resonance for structural confirmation. These methods can distinguish GW501516 from related PPAR agonists and from unrelated steroids. For regulators and researchers, such verification is central to interpreting both biological results and adverse event reports.
As late as 1808, the continental powers affirmed most of his gains and titles, but the continuing conflict with Britain led him to start the Peninsular War and the invasion of Russia, which many scholars see as a dramatic miscalculation.
Many mushroom species produce secondary metabolites that can be toxic, mind-altering, antibiotic, antiviral, or bioluminescent. Although there are only a small number of deadly species, several others can cause particularly severe and unpleasant symptoms. Toxicity likely plays a role in protecting the function of the basidiocarp: the mycelium has expended considerable energy and protoplasmic material to develop a structure to efficiently distribute its spores. One defense against consumption and premature destruction is the evolution of chemicals that render the mushroom inedible, either causing the consumer to vomit the meal (see emetics), or to learn to avoid consumption altogether. In addition, due to the propensity of mushrooms to absorb heavy metals, including those that are radioactive, as late as 2008, European mushrooms may have included toxicity from the 1986 Chernobyl disaster and have continued to be studied.
== Naval career == Upon his graduation from Tufts, Bello was commissioned an ensign in the United States Navy and served a four-year tour that included a tour of duty in South Vietnam as supply officer for PBR Mobile Base II on the Mekong Delta with a mission of combat support for several Patrol Boat, River (PBR) squadrons. He was awarded the Navy Commendation Medal with Combat V for meritorious service. In 1972, after Vietnam, Bello was assigned to the Moffett Field Naval Air Station Moffett Field as the Navy Exchange Officer. He resigned his commission as a Lieutenant to attend graduate school.
joint pain – the most common symptom, occurring in up to 86% of patients. The pain is often an aching or arthritis-like pain in the elbows, wrists, hands, and knees, in a symmetrical pattern. dry eyes dry mouth hair loss joint inflammation mouth ulcers Raynaud's phenomenon sun-sensitive rash Clinical presentation in some people diagnosed with UCTD may show :
Sources: en.wikipedia.org
== History == In October 1967, Techtron Pty Ltd merged with Varian Associates. Techtron is a manufacturer of Atomic Absorption Spectrometers and Spectral lamps. In 1982, Varian transferred the Cary UV-Visible product line to Australia. In 1997, Varian bought Chemagnetics, a Colorado-based manufacturer of solid-state NMR spectrometers. In 2002, Varian bought Ansys Technologies, Inc., a California-based manufacturer of In-Vitro Medical Devices. In 2004, Varian Inc bought Magnex Scientific, an Oxford-based manufacturer of high-field magnets. In 2005, Varian bought Polymer Laboratories, a speciality polymer analysis and manufacturing company. In 2006, Varian bought Ion Spec, an FTMS (Fourier Transform Mass Spectrometry) manufacturing company. In 2007, Varian, Inc. bought Analogix, Inc., a company specializing in flash chromatography. In 2008, Varian bought Oxford Diffraction, a British company specializing in X-ray diffraction equipment. On 27 July 2009, Agilent Technologies announced it would buy Varian Inc, for $1.5 Billion. On 14 October 2014, Agilent made the strategic decision to close its NMR business. Agilent entered the NMR business in 2010, with the acquisition of Varian. Several former Varian engineers have continued the business through private ventures, including the probe department spawning the company PhoenixNMR and the software being made open source.
==== Environmental remediation ==== Nanoremediation is the use of nanoparticles for environmental remediation. Nanoremediation has been most widely used for groundwater treatment, with additional extensive research in wastewater treatment. Nanoremediation has also been tested for soil and sediment cleanup. Even more preliminary research is exploring the use of nanoparticles to remove toxic materials from gases. Some nanoremediation methods, particularly the use of nano zerovalent iron for groundwater cleanup, have been deployed at full-scale cleanup sites. Nanoremediation is an emerging industry; by 2009, nanoremediation technologies had been documented in at least 44 cleanup sites around the world, predominantly in the United States. During nanoremediation, a nanoparticle agent must be brought into contact with the target contaminant under conditions that allow a detoxifying or immobilizing reaction. This process typically involves a pump-and-treat process or in situ application. Other methods remain in research phases. Scientists have been researching the capabilities of buckminsterfullerene in controlling pollution, as it may be able to control certain chemical reactions. Buckminsterfullerene has been demonstrated as having the ability of inducing the protection of reactive oxygen species and causing lipid peroxidation. This material may allow for hydrogen fuel to be more accessible to consumers.
In response, Conservative leader Kemi Badenoch accuses Farage of "manipulating" the publish by publishing "fake" figures and using an automated ticker to falsely inflate membership numbers. The following day, Farage threatens to "take some kind of action in the next couple of days", while the Reform website says the membership figure has increased to above 143,000. 27 December – Former Conservative Justice Secretary David Gauke, who is leading a review into sentencing and prison overcrowding, calls for greater use of open prisons in order to ease the pressure on closed category prisons. 29 December – Reform UK says it has notched up a further 20,000 members since the Kemi Badenoch row, reaching 150,000 members. Conservative Party allies of Kemi Badenoch reject claims she asked GB News to reduce Nigel Farage's airtime on the channel. 30 December – The King and the Prime Minister pay tribute to Jimmy Carter, following the former US president's death at the age of 100. Conor Murphy, a minister in the Northern Ireland Executive, announces he will contest the 2025 Seanad election in the Republic of Ireland for Sinn Féin, saying he will resign as a member of the Stormont Assembly if successful. 2025 New Year Honours: Those from the world of politics recognised in the New Year Honours include Sadiq Khan, Nick Gibb and Andy Street, who receive knighthoods, and Emily Thornberry, who receives a damehood.
Sources: en.wikipedia.org
It binds and activates PPARδ, a nuclear receptor that influences gene expression related to fatty acid metabolism and energy balance. This mechanism has been studied mainly in animals and cell models, not established as a safe human therapy.
No. It is not an anabolic-androgenic steroid; it is a synthetic PPARδ agonist. Because it is banned in sport, it is sometimes grouped with doping agents even though its chemical class differs from steroids.
Human data are limited and development was discontinued, so major effects and long-term risks are not well characterized. Some early studies examined metabolic markers, but they do not provide a basis for unsupervised use.
It binds to and activates PPAR delta, a nuclear receptor that controls expression of genes related to fatty acid oxidation. This mechanism can alter energy metabolism in animal models. It is not a direct stimulant or fat-burning enzyme.